Martingale Asset Management L P Adaptive Biotechnologies Corp Transaction History
Martingale Asset Management L P
- $4.02 Billion
- Q2 2025
A detailed history of Martingale Asset Management L P transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 25,145 shares of ADPT stock, worth $448,335. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,145
Previous 58,325
56.89%
Holding current value
$448,335
Previous $433,000
32.56%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ADPT
# of Institutions
267Shares Held
148MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$535 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$208 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$201 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$112 Million1.68% of portfolio
-
Nikko Asset Management Americas, Inc.4.3MShares$76.7 Million0.53% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.55B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...